Copyright Reports & Markets. All rights reserved.

Global Cancer Pain Therapeutics Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Cancer Pain Therapeutics

      • 1.1 Definition of Cancer Pain Therapeutics
      • 1.2 Cancer Pain Therapeutics Segment by Type
        • 1.2.1 Global Cancer Pain Therapeutics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Opioids
        • 1.2.3 Non-Steroidal Anti-Inflammatory Drugs
        • 1.2.4 Others
      • 1.3 Cancer Pain Therapeutics Segment by Applications
        • 1.3.1 Global Cancer Pain Therapeutics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Paracetamol Treatment-Related Immunotherapy
        • 1.3.3 Radiotherapy
        • 1.3.4 Chemotherapy
        • 1.3.5 Hormone Therapy
      • 1.4 Global Cancer Pain Therapeutics Overall Market
        • 1.4.1 Global Cancer Pain Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Cancer Pain Therapeutics Production (2014-2025)
        • 1.4.3 North America Cancer Pain Therapeutics Status and Prospect (2014-2025)
        • 1.4.4 Europe Cancer Pain Therapeutics Status and Prospect (2014-2025)
        • 1.4.5 China Cancer Pain Therapeutics Status and Prospect (2014-2025)
        • 1.4.6 Japan Cancer Pain Therapeutics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Cancer Pain Therapeutics Status and Prospect (2014-2025)
        • 1.4.8 India Cancer Pain Therapeutics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Cancer Pain Therapeutics
      • 2.3 Manufacturing Process Analysis of Cancer Pain Therapeutics
      • 2.4 Industry Chain Structure of Cancer Pain Therapeutics

      3 Development and Manufacturing Plants Analysis of Cancer Pain Therapeutics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Cancer Pain Therapeutics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Cancer Pain Therapeutics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Cancer Pain Therapeutics Production and Capacity Analysis
      • 4.2 Cancer Pain Therapeutics Revenue Analysis
      • 4.3 Cancer Pain Therapeutics Price Analysis
      • 4.4 Market Concentration Degree

      5 Cancer Pain Therapeutics Regional Market Analysis

      • 5.1 Cancer Pain Therapeutics Production by Regions
        • 5.1.1 Global Cancer Pain Therapeutics Production by Regions
        • 5.1.2 Global Cancer Pain Therapeutics Revenue by Regions
      • 5.2 Cancer Pain Therapeutics Consumption by Regions
      • 5.3 North America Cancer Pain Therapeutics Market Analysis
        • 5.3.1 North America Cancer Pain Therapeutics Production
        • 5.3.2 North America Cancer Pain Therapeutics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Cancer Pain Therapeutics Import and Export
      • 5.4 Europe Cancer Pain Therapeutics Market Analysis
        • 5.4.1 Europe Cancer Pain Therapeutics Production
        • 5.4.2 Europe Cancer Pain Therapeutics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Cancer Pain Therapeutics Import and Export
      • 5.5 China Cancer Pain Therapeutics Market Analysis
        • 5.5.1 China Cancer Pain Therapeutics Production
        • 5.5.2 China Cancer Pain Therapeutics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Cancer Pain Therapeutics Import and Export
      • 5.6 Japan Cancer Pain Therapeutics Market Analysis
        • 5.6.1 Japan Cancer Pain Therapeutics Production
        • 5.6.2 Japan Cancer Pain Therapeutics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Cancer Pain Therapeutics Import and Export
      • 5.7 Southeast Asia Cancer Pain Therapeutics Market Analysis
        • 5.7.1 Southeast Asia Cancer Pain Therapeutics Production
        • 5.7.2 Southeast Asia Cancer Pain Therapeutics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Cancer Pain Therapeutics Import and Export
      • 5.8 India Cancer Pain Therapeutics Market Analysis
        • 5.8.1 India Cancer Pain Therapeutics Production
        • 5.8.2 India Cancer Pain Therapeutics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Cancer Pain Therapeutics Import and Export

      6 Cancer Pain Therapeutics Segment Market Analysis (by Type)

      • 6.1 Global Cancer Pain Therapeutics Production by Type
      • 6.2 Global Cancer Pain Therapeutics Revenue by Type
      • 6.3 Cancer Pain Therapeutics Price by Type

      7 Cancer Pain Therapeutics Segment Market Analysis (by Application)

      • 7.1 Global Cancer Pain Therapeutics Consumption by Application
      • 7.2 Global Cancer Pain Therapeutics Consumption Market Share by Application (2014-2019)

      8 Cancer Pain Therapeutics Major Manufacturers Analysis

      • 8.1 BioDelivery Science
        • 8.1.1 BioDelivery Science Cancer Pain Therapeutics Production Sites and Area Served
        • 8.1.2 BioDelivery Science Product Introduction, Application and Specification
        • 8.1.3 BioDelivery Science Cancer Pain Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 ProStrakan Group
        • 8.2.1 ProStrakan Group Cancer Pain Therapeutics Production Sites and Area Served
        • 8.2.2 ProStrakan Group Product Introduction, Application and Specification
        • 8.2.3 ProStrakan Group Cancer Pain Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Teva pharmaceuticals
        • 8.3.1 Teva pharmaceuticals Cancer Pain Therapeutics Production Sites and Area Served
        • 8.3.2 Teva pharmaceuticals Product Introduction, Application and Specification
        • 8.3.3 Teva pharmaceuticals Cancer Pain Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Eli-Lilly
        • 8.4.1 Eli-Lilly Cancer Pain Therapeutics Production Sites and Area Served
        • 8.4.2 Eli-Lilly Product Introduction, Application and Specification
        • 8.4.3 Eli-Lilly Cancer Pain Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Grunenthal Group
        • 8.5.1 Grunenthal Group Cancer Pain Therapeutics Production Sites and Area Served
        • 8.5.2 Grunenthal Group Product Introduction, Application and Specification
        • 8.5.3 Grunenthal Group Cancer Pain Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 GW Pharmaceuticals
        • 8.6.1 GW Pharmaceuticals Cancer Pain Therapeutics Production Sites and Area Served
        • 8.6.2 GW Pharmaceuticals Product Introduction, Application and Specification
        • 8.6.3 GW Pharmaceuticals Cancer Pain Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Johnson＆Johnson
        • 8.7.1 Johnson＆Johnson Cancer Pain Therapeutics Production Sites and Area Served
        • 8.7.2 Johnson＆Johnson Product Introduction, Application and Specification
        • 8.7.3 Johnson＆Johnson Cancer Pain Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Meda Pharmaceuticals
        • 8.8.1 Meda Pharmaceuticals Cancer Pain Therapeutics Production Sites and Area Served
        • 8.8.2 Meda Pharmaceuticals Product Introduction, Application and Specification
        • 8.8.3 Meda Pharmaceuticals Cancer Pain Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Orexo
        • 8.9.1 Orexo Cancer Pain Therapeutics Production Sites and Area Served
        • 8.9.2 Orexo Product Introduction, Application and Specification
        • 8.9.3 Orexo Cancer Pain Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Sanofi
        • 8.10.1 Sanofi Cancer Pain Therapeutics Production Sites and Area Served
        • 8.10.2 Sanofi Product Introduction, Application and Specification
        • 8.10.3 Sanofi Cancer Pain Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 WEX Pharmaceuticals

      9 Development Trend of Analysis of Cancer Pain Therapeutics Market

      • 9.1 Global Cancer Pain Therapeutics Market Trend Analysis
        • 9.1.1 Global Cancer Pain Therapeutics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Cancer Pain Therapeutics Regional Market Trend
        • 9.2.1 North America Cancer Pain Therapeutics Forecast 2019-2025
        • 9.2.2 Europe Cancer Pain Therapeutics Forecast 2019-2025
        • 9.2.3 China Cancer Pain Therapeutics Forecast 2019-2025
        • 9.2.4 Japan Cancer Pain Therapeutics Forecast 2019-2025
        • 9.2.5 Southeast Asia Cancer Pain Therapeutics Forecast 2019-2025
        • 9.2.6 India Cancer Pain Therapeutics Forecast 2019-2025
      • 9.3 Cancer Pain Therapeutics Market Trend (Product Type)
      • 9.4 Cancer Pain Therapeutics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Cancer Pain Therapeutics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response.
        Factors such as the unmet medical needs of patients drive the market growth during the forecast period. Currently, the drugs that are available for reducing pains associated with cancer have a prolonged duration of action and are characterized by undesirable effects like sedation and respiratory depression. Consequently, this presents an opportunity for the vendors to bring in therapies with fewer side effects and a better efficacy parameter.

        The global Cancer Pain Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Cancer Pain Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Pain Therapeutics market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Pain Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Cancer Pain Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        BioDelivery Science
        ProStrakan Group
        Teva pharmaceuticals
        Eli-Lilly
        Grunenthal Group
        GW Pharmaceuticals
        Johnson＆Johnson
        Meda Pharmaceuticals
        Orexo
        Sanofi
        WEX Pharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Opioids
        Non-Steroidal Anti-Inflammatory Drugs
        Others

        Segment by Application
        Paracetamol Treatment-Related Immunotherapy
        Radiotherapy
        Chemotherapy
        Hormone Therapy

        Buy now